Testing effectiveness (Phase 2)Study completedNCT03725722
What this trial is testing
Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.
Who this might be right for
Atopic Dermatitis
LEO Pharma 251